In 50% of these subjects, all of whom had an advanced form of the disease, the inflammation readings for aMMP-8, an enzyme that destroys tissue, were completely normalised within 12 weeks. Within 16 weeks, 60% of subjects showed the same result – i.e. tissue loss and pocket formation were halted. The periodontium was healed and aMMP-8 activity reduced to the healthy 'green zone' of < 8 ng/ml (see diagram below).

Further operations or probiotic treatment were unnecessary. Even the remaining 40% of subjects showed a reduction in inflammation, as measured via aMMP-8 levels.

The accompanying purification of the intestines was equally convincing and accorded with the reduced levels of aMMP-8 in the tooth neck as a measure for the reduction of tissue loss.

In 2013, the aMMP-8 study was assigned the CAM Award in Düsseldorf by the health minister. Then, at the beginning of 2014, here at hypo-A we refined the treatment concept as a user-friendly dietary supplement. It is now available as a packaged, four-stage blister pack supplement programme, with each stage designed to be taken over 28 days. This simple and effective four-month treatment is therefore easy to take and follow through, for clinicians as much as patients.

This innovative natural treatment programme comes with its own 12-page periodontitis brochure that provides an easy-to-understand explanation of chronic illness, its development throughout the body and how it can be treated biologically. Order by fax or by email and hypo-A will send you the patient information. Below you will find the contents of the brochure. Clinicians can receive specialist information, along with copies of the patient information for their practices, on request.

Our natural approach to the treatment of periodontitis using Itis Protect® is based on 25 years' experience of treating chronic disease. While treating people for intestinal, back or knee joint problems, we noticed that inflammation due to periodontitis often cleared up as well. So for the past twenty years, here at our natural treatment centre for general medical problems, we have been receiving patients with advanced oral inflammation who are in danger of losing their teeth.

In 2011, following the development of a therapy specifically designed for diseases of the periodontium, a study of this simple three or four-month treatment concept was published. The study had been carried out in a group of patients with chronic aggressive periodontitis (the most advanced form) who in the past two years had had at least four standard treatments involving antibiotics or other methods without seeing any improvement.